Oncology News

• First ALL Treatment Guidance for Young Patients in the Works : The American Society of Hematology is developing the first clinical practice guidelines for treating acute lymphocytic leukemia in adolescents and young adults.
  MDedge News, January 09, 2024
• Nodal Radiation May Make BC Axillary Dissection Unnecessary Some patients with breast cancer may be able to skip axillary lymph node dissection if they plan to have adjuvant nodal radiation.
  MDedge News, January 08, 2024
• Gastric Cancer Survival Differs by Race and Ethnicity Overall, Asian and Hispanic patients demonstrated better survival than White and Black patients.
  Medscape Medical News, January 08, 2024
• Some Breast Cancer Surgery Patients Travel Further For Care Decision-making can be based on media prestige.
  Medscape News UK, January 08, 2024
• Active Surveillance for Low-Risk PCa: Sprint or Marathon? No easy algorithm for men who prefer to watch, rather than treat, their prostate cancers.
  Medscape Medical News, January 05, 2024
• Magnetic Seeds/Guidewires for Breast Cancer Localization? Paramagnetic seeds work as well as guidewires for breast tumor localization and are easier to use, but it's not yet clear whether the costs of the seeds outweigh the benefits.
  Medscape Medical News, January 05, 2024
• 'Left in the Dark': Prior Auth Erodes Trust, Costs More A surprising prior authorization requirement left an oncologist's patient in extreme pain over the weekend.
  Medscape Medical News, January 04, 2024
• Prior Auth Tied to Delays, Discontinuation of Cancer Meds The introduction of a new prior authorization requirement for an established oral anticancer regimen led to more treatment delays and discontinuations among Medicare beneficiaries.
  Medscape Medical News, January 04, 2024
• Optimal Follow-up After Cervical Cancer Surgery Instead of using a one-size-fits-all approach, monitoring for cancer recurrence after fertility-sparing cervical cancer surgery can be tailored based on HPV testing and cytology.
  Medscape Medical News, January 03, 2024
• Artificial Sweeteners Alter the Duodenal Microbiome Nonsugar sweeteners affected the stool and small bowel microbiomes differently, and the type of sweetener consumed proved relevant to which microbiome changes occurred.
  Medscape Medical News, January 03, 2024
• Who Is Helped by AI Use During Colonoscopy? The evidence is conflicting but suggests overall that using AI devices during colonoscopy will help endoscopists at every level, particularly as the technology is refined going forward.
  Medscape Medical News, December 29, 2023
• How Do Patients View Their Cancer Test Results? With electronic patient portals, patients see their test results sooner and more frequently before their clinician, a recent analysis found.
  Medscape Medical News, December 28, 2023
• No Added Benefit From Chemo in This Breast Cancer Subtype Adding chemotherapy to endocrine therapy for women with ER-positive, HER2-negative invasive lobular carcinoma does not improve survival outcomes.
  Medscape Medical News, December 28, 2023
• Record-High Wait Lists for Cancer, Other Surgeries in Quebec The passage of Bill 15, a wide-ranging healthcare reform proposal, could provide relief but not in the short term.
  Medscape Medical News, December 28, 2023
• New Trials in Breast Cancer: Could Your Patient Benefit? Patients with breast cancer might be eligible to enroll in one of these clinical trials.
  Medscape Medical News, December 27, 2023
• Death Risk Takes Decades to Revert to Normal in Ex-Smokers Former smokers can reduce their cardiovascular mortality risk by 100%, cancer-related mortality risk by 93%, and respiratory-related mortality risk by 97%.
  Medscape Medical News, December 27, 2023
• ICIs in Melanoma: Predicting Immune-related Adverse Events Melanoma histopathology predicted which patients were most likely to develop immune-related adverse events while taking checkpoint inhibitors.
  Medscape Medical News, December 26, 2023
• The Latest Findings on Major Breast Cancer Trials Here's a roundup of the most recent data from five phase 3 trials presented at SABCS 2023.
  Medscape Medical News, December 21, 2023
• Serum Hormones May Predict AI Benefit for BC Prevention Measuring serum hormone concentrations in postmenopausal women at high risk for developing BC may help identify those most likely to benefit from preventive treatment with an aromatase inhibitor.
  Medscape Medical News, December 21, 2023
• ESD Curbs Adenoma Recurrence but More Adverse Events For large colonic adenomas, endoscopic submucosal dissection reduces the recurrence rate compared with endoscopic mucosal resection, but the adverse event rate is higher.
  Medscape Medical News, December 20, 2023
• Top 10 Fictional Docs on Streaming TV Both tried-and-true and out-of-the-ordinary holiday gift ideas are offered to those seeking a great present for a physician.
  Medscape News Slideshows, December 15, 2023
• ASH 2023 ASH 2023: Equity, Sickle Cell, and Real-Life Outcomes Health equity, sickle cell disease, and the thoughtful use of artificial intelligence and social media are among the key themes to be presented at the annual meeting of the American Society of Hematology.
  MDedge News, December 04, 2023
• How the Microbiome Influences the Success of Cancer Therapy Microbial diversity affects whether a tumor grows, leads to inflammation, develops immune escape mechanisms, or develops therapeutic resistance, said an internal medicine specialist.
  Medscape Medical News, December 04, 2023
• MSWS 2023 New Tools Available to Help Diagnose Skin Cancer Emerging technologies aim to improve skin cancer diagnosis without biopsies.
  Medscape Medical News, December 03, 2023
• MSWS 2023 Misdiagnoses Among Challenges in Managing Cutaneous Lymphoma Although predictive tools to identify those at risk of disease progression are in their infancy, the development of such tools is crucial for improving patient outcomes.
  Medscape Medical News, December 02, 2023
• What Is the Dark Side of GLP-1 Receptor Agonists? Doctors who prescribe this class of medication should be aware of the rare side effects with which it is associated, said an obesity expert.
  Medscape Medical News, December 01, 2023
• SABCS 2023 SABCS 2023 Highlights Breast Cancer De-Escalation From humble beginnings in 1977, 10,000 people are expected to attend this year's breast cancer meeting in San Antonio.
  Medscape Medical News, December 01, 2023
• ASCO Details How to Manage Ongoing Cancer Drug Shortage The guidance also recommends counseling to help patients and providers who are struggling with 'psychological or moral distress' from ongoing shortages.
  Medscape Medical News, November 30, 2023
• Pancreatic Cystic Neoplasms Rarely Turn Cancerous Individuals with intraductal papillary mucinous neoplasms that lack 'worrisome or high-risk features' have no greater risk of pancreatic cancer than individuals without IPMNs.
  MDedge News, November 30, 2023
• Small-Volume Bloodwork Tubes May Reduce Transfusions in ICUs Decreasing blood supply use could also preserve blood products for patients undergoing cancer treatment or surgery and for those with trauma or other illnesses.
  Medscape Medical News, November 30, 2023
• Avoid Anti-HER2 Cancer Therapies During Pregnancy Women with HER2-positive breast cancer who receive HER2-targeted therapies during pregnancy face a higher risk for severe adverse outcomes to their fetus or newborn, new research indicates.
  Medscape Medical News, November 29, 2023
• MRIs, MRI-Guided Biopsies Detect Prostate Cancer Affordably Standard biopsies sometimes fail to detect prostate cancer or produce false positives. MRI plus MRI-guided biopsies not only produce more accurate results but carry a fair price tag, researchers said.
  Medscape Medical News, November 29, 2023
• Alert FDA Investigates Secondary Cancers From CAR T-Cell Therapies The FDA has determined that the risk for lymphoma and other T-cell cancers may apply to approved BCMA- and CD-19–directed CAR T-cell immunotherapies.
  Medscape Medical News, November 28, 2023
• Alert FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia The new colony-stimulating factor from China proved comparable to pegfilgrastim (Neulasta) in clinical testing.
  Medscape Medical News, November 28, 2023
• ASTRO Updates on Partial Breast Irradiation in Early Cancer The new guideline replaces 2017 guidance after new evidence from multiple large trials emerged, indicating comparable outcomes with partial and whole breast radiation.
  Medscape Medical News, November 28, 2023
• Long-Term Organ Preservation in Rectal Cancer Is Possible Long-term data from the OPRA trial show organ preservation at 5 years in about half of patients with stage II/III rectal adenocarcinoma who received total neoadjuvant therapy.
  Medscape Medical News, November 28, 2023
• AANEM 2023 Novel Myasthenia Gravis Therapies Bring Opportunities New treatments for myasthenia gravis are bringing new promise to patients, but their use must be balanced against short-term and long-term risks.
  MDedge News, November 27, 2023
• Alert FDA Approves Nirogacestat for Desmoid Tumors This is the first drug approved to treat desmoid tumors.
  Medscape Medical News, November 27, 2023
• Grail Gets FDA OK for Study of Cancer Blood Test Grail announced a step that may help move the company closer to securing Medicare reimbursement for its Galleri multicancer blood test, sold in the US since 2021.
  Medscape Medical News, November 27, 2023
• White House Appoints New NCI Director After years of working with the National Cancer Institute, W. Kimryn Rathmell, MD, PhD, gets the call to run the institute.
  Medscape Medical News, November 22, 2023